The FinnProstate Study VII: Intermittent Versus Continuous Androgen Deprivation in Patients With Advanced Prostate Cancer

Studies on Prostatic Cancer. I. The Effect of Castration, of Estrogen and of Androgen Injection on Serum Phosphatases in Metastatic Carcinoma of the Prostate

1941 • 3,235 citations

Studies on prostatic cancer

2002 • 701 citations

Absolute Prostate-Specific Antigen Value After Androgen Deprivation Is a Strong Independent Predictor of Survival in New Metastatic Prostate Cancer: Data From Southwest Oncology Group Trial 9346 (INT-0162)

2006 • 474 citations

Review of major adverse effects of androgen‐deprivation therapy in men with prostate cancer

2009 • 295 citations

Intermittent Androgen Deprivation for Locally Advanced and Metastatic Prostate Cancer: Results from a Randomised Phase 3 Study of the South European Uroncological Group

2009 • 243 citations

Potential Benefits of Intermittent Androgen Suppression Therapy in the Treatment of Prostate Cancer: A Systematic Review of the Literature

2009 • 189 citations

Using PSA to Guide Timing of Androgen Deprivation in Patients with T0–4 N0–2 M0 Prostate Cancer not Suitable for Local Curative Treatment (EORTC 30891)

2007 • 148 citations

Intermittent Versus Continuous Total Androgen Blockade in the Treatment of Patients with Advanced Hormone-Naive Prostate Cancer: Results of a Prospective Randomized Multicenter Trial

2002 • 137 citations

Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer

2006 • 121 citations

A PROSPECTIVE ANALYSIS OF TIME TO NORMALIZATION OF SERUM TESTOSTERONE AFTER WITHDRAWAL OF ANDROGEN DEPRIVATION THERAPY

2000 • 112 citations

Intermittent Androgen Suppression for Prostate Cancer: Rationale and Clinical Experience

1998 • 91 citations

A PROSPECTIVE ANALYSIS OF THE TIME TO NORMALIZATION OF SERUM ANDROGENS FOLLOWING 6 MONTHS OF ANDROGEN DEPRIVATION THERAPY IN PATIENTS ON A RANDOMIZED PHASE III CLINICAL TRIAL USING LIMITED HORMONAL THERAPY

2005 • 77 citations

A 10-Year Clinical Experience with Intermittent Hormonal Therapy for Prostate Cancer

2003 • 70 citations

Intermittent androgen suppression for prostate cancer: rationale and clinical experience

1998 • 69 citations

The role of intermittent androgen deprivation in prostate cancer

2007 • 67 citations

Intermittent androgen blockade should be regarded as standard therapy in prostate cancer

2008 • 58 citations

Intermittent Maximal Androgen Blockade in Patients with Metastatic Prostate Cancer: An EORTC Feasibility Study

2003 • 54 citations

Complications of androgen deprivation therapy in prostate cancer

2009 • 44 citations

Intermittent Complete Androgen Blockade in Metastatic Prostate Cancer

1999 • 38 citations

Continuous versus Six Months a Year Maximal Androgen Blockade in the Management of Prostate Cancer: A Randomised Study

2008 • 38 citations

Finnish Multicenter Study Comparing Intermittent to Continuous Androgen Deprivation for Advanced Prostate Cancer: Interim Analysis of Prognostic Markers Affecting Initial Response to Androgen Deprivation

2008 • 32 citations

The change of PSA doubling time and its association with disease progression in patients with biochemically relapsed prostate cancer treated with intermittent androgen Deprivation

2011 • 29 citations

Androgen deprivation therapy for patients with clinically localized (stages T1 to T3) prostate cancer and for patients with biochemical recurrence after radical prostatectomy

2001 • 27 citations

Intermittent androgen deprivation therapy: redefining the standard of care?

2010 • 25 citations

A 16-year clinical experience with intermittent androgen deprivation for prostate cancer: oncological results

2009 • 20 citations